Please contact Scott Hall at email@example.com or 202-463-5817.
Achieving the Unimaginable, Innovation in Healthcare
By Matt Harakal
A cancer diagnosis used to leave patients with little hope.
But now, researchers at St. Jude’s Children’s Research Hospital are using a patented innovative gene therapy treatment to treat anaplastic large cell lymphoma (ALCL), and are examining other ways in which the treatment may be used.
Imagine thinking you’ll never be able to see again, but then one day you can see family and friends for the first time.
Second Sight’s Argus II bionic eye system is giving that gift.
Everyone has felt the painful stick from a needle during a doctor’s visit. Picture forgoing that needle stick but having your physician still be able to use a sensor to get the results they need?
With the noninvasive medical monitoring technology developed by medical technology company Masimo, this has become a reality in many situations.
These three businesses are some of the many leading the way in innovative new medical technologies creating a better society – and a better life – for citizens around the world.
How did these once unimaginable inventions come to market? Amazing minds, groundbreaking research and the underpinning of intellectual property (IP).
In the United States, the role IP plays in our society is tremendous in both medial and economic terms.
IP-intensive companies account for more than $5 trillion of U.S. GDP, drive 60% of U.S. exports, and support 40 million American jobs.
These are all part of the reasons these three organizations – St. Jude’s Children Research Hospital, Second Sight, and Masimo – will be awarded as IP Champions at GIPC’s annual event on April 20, 2015. Each has successfully found the right combination of new health technologies with market resources to create businesses to deliver these life changing advances to patients.
GIPC’s IP Champions event coincides with World IP Day, which occurs on April 26th every year to raise awareness of the important role IP plays in spurring innovation.
Over the next few days we’ll continue to highlight some of the leading innovators and organizations utilizing IP to develop new breakthrough technologies to improving and save lives.
Please join us on April 20 to hear directly from these innovators about the great work they’re doing, and what they have planned for the future. Check out the agenda and register here.
Global Innovation Policy Center @globalIPcenter 22h
“[An #IP waiver] would be a destructive policy even if it were necessary, but it is not necessary — it is not even likely to prove beneficial for the purpose at hand, which is helping to speed the pace of global vaccinations.” https://t.co/utPA1XuuqU